Government-led scientific studies from across Europe’s most progressive cannabis markets are solidifying an evidence base suggesting that greater access does not cause greater harm to public health.
Last week, Spain’s government approved a draft tobacco law that never once mentions cannabis, yet could dismantle the everyday activity of the country’s thriving cannabis social clubs.
The Drug Enforcement Administration’s (DEA) administrative hearing on cannabis rescheduling saw both sides make their closing arguments on Wednesday, July 15, bringing the 17-day proceedings to a broadly positive close.
Tomorrow (July 15, 2026) the landmark administrative hearing on US cannabis rescheduling will come to a close.
This week, what is perhaps the most consequential hearing in the history of the US, and indeed the global cannabis industry, is taking place in Arlington, Virginia.
Switzerland has granted approval for a new five-year, 5000-participant adult-use cannabis pilot trial, marking the eighth since the groundbreaking project began in 2023.
On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA Administrative Law Judge (ALJ) hearing that could determine whether adult-use cannabis joins state-licensed medical cannabis on Schedule III of the Controlled Substances Act, begins proceedings.
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes.
AUSTRALIAN medical cannabis sales tanked by over a quarter in the second half of 2025, following a clampdown on the previous ‘profit before patient’ model A report from the Penington Institute shows that medical cannabis sales peaked in the second half of 2024 at 3.72m units before falling to 2.65m units in the second half…
